News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
785,221 Results
Type
Article (71027)
Company Profile (643)
Press Release (713549)
Multimedia
Podcasts (126)
Webinars (19)
Section
Business (220574)
Career Advice (2927)
Deals (38114)
Drug Delivery (120)
Drug Development (86773)
Employer Resources (182)
FDA (17301)
Job Trends (16540)
News (372956)
Policy (35065)
Tag
Academia (2906)
Academic (2)
Accelerated approval (10)
Adcomms (23)
Allergies (105)
Alliances (55076)
ALS (119)
Alzheimer's disease (1557)
Antibody-drug conjugate (ADC) (183)
Approvals (17261)
Artificial intelligence (356)
Autoimmune disease (36)
Automation (17)
Bankruptcy (390)
Best Places to Work (12293)
BIOSECURE Act (22)
Biosimilars (130)
Biotechnology (439)
Bladder cancer (97)
Brain cancer (39)
Breast cancer (382)
Cancer (3032)
Cardiovascular disease (239)
Career advice (2463)
Career pathing (34)
CAR-T (206)
CDC (36)
Cell therapy (559)
Cervical cancer (24)
Clinical research (70741)
Collaboration (1104)
Company closure (3)
Compensation (704)
Complete response letters (33)
COVID-19 (2850)
CRISPR (65)
C-suite (350)
Cystic fibrosis (119)
Data (3061)
Decentralized trials (2)
Denatured (45)
Depression (74)
Diabetes (368)
Diagnostics (6883)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (157)
Drug pricing (143)
Drug shortages (33)
Duchenne muscular dystrophy (131)
Earnings (90600)
Editorial (48)
Employer branding (24)
Employer resources (160)
Events (123942)
Executive appointments (907)
FDA (18996)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1004)
Gene editing (144)
Generative AI (33)
Gene therapy (424)
GLP-1 (906)
Government (4583)
Grass and pollen (6)
Guidances (179)
Healthcare (20016)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (178)
Immuno-oncology (10)
Indications (40)
Infectious disease (3039)
Inflammatory bowel disease (161)
Inflation Reduction Act (13)
Influenza (69)
Intellectual property (123)
Interviews (547)
IPO (17605)
IRA (53)
Job creations (4714)
Job search strategy (2060)
Kidney cancer (14)
Labor market (50)
Layoffs (581)
Leadership (26)
Legal (8732)
Liver cancer (84)
Lung cancer (424)
Lymphoma (213)
Machine learning (11)
Management (63)
Manufacturing (426)
MASH (97)
Medical device (14499)
Medtech (14504)
Mergers & acquisitions (21232)
Metabolic disorders (933)
Multiple sclerosis (104)
NASH (20)
Neurodegenerative disease (139)
Neuropsychiatric disorders (39)
Neuroscience (2303)
NextGen: Class of 2025 (7216)
Non-profit (4767)
Now hiring (48)
Obesity (475)
Opinion (286)
Ovarian cancer (103)
Pain (119)
Pancreatic cancer (125)
Parkinson's disease (198)
Partnered (24)
Patents (314)
Patient recruitment (167)
Peanut (55)
People (63373)
Pharmaceutical (132)
Pharmacy benefit managers (22)
Phase I (22020)
Phase II (30974)
Phase III (23240)
Pipeline (1681)
Policy (223)
Postmarket research (2964)
Preclinical (9872)
Press Release (72)
Prostate cancer (148)
Psychedelics (44)
Radiopharmaceuticals (277)
Rare diseases (510)
Real estate (6846)
Recruiting (74)
Regulatory (24400)
Reports (44)
Research institute (2647)
Resumes & cover letters (444)
Rett syndrome (10)
RNA editing (10)
RSV (57)
Schizophrenia (98)
Series A (172)
Series B (118)
Service/supplier (27)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (165)
Sponsored (37)
Startups (4146)
State (2)
Stomach cancer (16)
Supply chain (80)
Tariffs (63)
The Weekly (79)
Vaccines (888)
Venture capital (57)
Weight loss (313)
Women's health (48)
Worklife (20)
Date
Today (48)
Last 7 days (428)
Last 30 days (1928)
Last 365 days (33068)
2025 (17737)
2024 (37578)
2023 (42323)
2022 (53680)
2021 (58226)
2020 (56789)
2019 (49671)
2018 (37823)
2017 (35857)
2016 (36206)
2015 (42507)
2014 (36594)
2013 (32657)
2012 (33688)
2011 (33713)
2010 (32157)
Location
Africa (1025)
Alabama (70)
Alaska (7)
Arizona (233)
Arkansas (14)
Asia (47925)
Australia (8167)
California (7721)
Canada (2401)
China (722)
Colorado (334)
Connecticut (343)
Delaware (202)
Europe (106612)
Florida (1146)
Georgia (257)
Hawaii (2)
Idaho (64)
Illinois (687)
India (31)
Indiana (382)
Iowa (18)
Japan (237)
Kansas (114)
Kentucky (33)
Louisiana (17)
Maine (72)
Maryland (1068)
Massachusetts (5916)
Michigan (267)
Minnesota (480)
Mississippi (3)
Missouri (100)
Montana (31)
Nebraska (26)
Nevada (80)
New Hampshire (73)
New Jersey (2168)
New Mexico (31)
New York (2178)
North Carolina (1223)
North Dakota (9)
Northern California (3334)
Ohio (251)
Oklahoma (16)
Oregon (46)
Pennsylvania (1650)
Puerto Rico (18)
Rhode Island (39)
South America (1403)
South Carolina (36)
South Dakota (1)
Southern California (2850)
Tennessee (127)
Texas (1162)
United States (28992)
Utah (227)
Virginia (207)
Washington D.C. (78)
Washington State (678)
West Virginia (4)
Wisconsin (81)
785,221 Results for "yeda research and development company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chugai and Gero Enter into Joint Research and License Agreement to Develop Novel Therapies for Age-Related Diseases
July 8, 2025
·
3 min read
Press Releases
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses
Company Is Advancing Use of Novel Doxorubicin-containing Microneedle Array (D-MNA) Patch in Veterinary Oncology as an Orphan Drug
June 9, 2025
·
10 min read
Bio NC
CoImmune, Inc. Announces Research Collaboration with Yeda Research and Development Company Ltd.
CoImmune, Inc. announced a research collaboration with Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science, to evaluate the applications of the Synthetic Immune Niche technology, developed by Weizmann Institute’s researchers to enhance the expansion and function of human cytokine induced killer cells expressing chimeric antigen receptors.
November 17, 2021
·
3 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Press Releases
Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic
July 10, 2025
·
5 min read
Press Releases
Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials
May 8, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
June 23, 2025
·
1 min read
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
Medicus Pharma Ltd. to Present at 2025 Bio International Convention
Company Executive Chairman & CEO to Provide Corporate Updates on June 17th 2025
June 12, 2025
·
6 min read
Press Releases
Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer
June 18, 2025
·
6 min read
1 of 78,523
Next
